Dar Zavain - Insider Non-Derivative Transactions at RECURSION PHARMACEUTICALS, INC. (RXRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 1, 2025, Dar Zavain's relationship to RECURSION PHARMACEUTICALS, INC. (RXRX) is Director, and currently has 138,758 shares of Class A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RXRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Dar Zavain - Insider Non-Derivative Transactions of RXRX Class A Common Stock

Dar Zavain - Insider Non-Derivative Transactions at RXRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 2, 2025	Acquisition -- (Class A Common Stock)	2941	0	138758
Jul 2, 2025	Acquisition -- (Class A Common Stock)	2924	0	135817
Jun 19, 2025	Acquisition -- (Class A Common Stock)	22016	0	132893
Apr 2, 2025	Acquisition -- (Class A Common Stock)	2745	0	110877
Jan 3, 2025	Acquisition -- (Class A Common Stock)	1907	0	108132
Oct 2, 2024	Acquisition -- (Class A Common Stock)	2229	0	106225
Jul 2, 2024	Acquisition -- (Class A Common Stock)	1843	0	103996
Jun 4, 2024	Acquisition -- (Class A Common Stock)	13097	0	102153
Apr 2, 2024	Acquisition -- (Class A Common Stock)	1467	0	89056
Jan 3, 2024	Acquisition -- (Class A Common Stock)	1393	0	55216
Dec 15, 2023	Sell -- (Class A Common Stock)	20141	9	53823
Oct 3, 2023	Acquisition -- (Class A Common Stock)	1920	0	73964
Jul 4, 2023	Acquisition -- (Class A Common Stock)	1863	0	72044
Jun 17, 2023	Acquisition -- (Class A Common Stock)	12612	0	70181
Apr 4, 2023	Acquisition -- (Class A Common Stock)	1996	0	22561
Apr 4, 2023	Acquisition -- (Class A Common Stock)	1996	0	57569